Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to 0.85.

  • Pulse Biosciences' Equity Ratio rose 21.06% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year increase of 21.06%. This contributed to the annual value of 0.87 for FY2024, which is 1563.36% up from last year.
  • As of Q3 2025, Pulse Biosciences' Equity Ratio stood at 0.85, which was up 21.06% from 0.87 recorded in Q2 2025.
  • Pulse Biosciences' Equity Ratio's 5-year high stood at 0.89 during Q1 2025, with a 5-year trough of 0.15 in Q1 2023.
  • In the last 5 years, Pulse Biosciences' Equity Ratio had a median value of 0.75 in 2021 and averaged 0.61.
  • Examining YoY changes over the last 5 years, Pulse Biosciences' Equity Ratio showed a top increase of 269788.74% in 2023 and a maximum decrease of 12888.06% in 2023.
  • Pulse Biosciences' Equity Ratio (Quarter) stood at 0.75 in 2021, then tumbled by 103.85% to 0.03 in 2022, then surged by 2697.89% to 0.75 in 2023, then grew by 15.63% to 0.87 in 2024, then decreased by 1.72% to 0.85 in 2025.
  • Its Equity Ratio stands at 0.85 for Q3 2025, versus 0.87 for Q2 2025 and 0.89 for Q1 2025.